Retinal dystrophy is an inherited, heterogeneous, chronic and progressive disorder of visual functions. The mutations of patients with autosomal recessive retinal retinopathy cone-and-rod dysfunction and macular dystrophy have not been well described in the Chinese population. In this study, a three-generation Chinese retinal dystrophy family was recruited. Ophthalmic examinations were performed. Targeted next generation sequencing (TGS) was used to identify causative genes, and Sanger sequencing was conducted to verify candidate mutations and co-segregation. Reverse transcription (RT)-PCR was applied to investigate the spatial and temporal expression patterns of cdhr1 gene in mouse. A novel, homozygous, deleterious and nonsense variant (c.T1641A; p.Y547*) in the CDHR1 gene was identified in the family with autosomal recessive retinal dystrophy, which was co-segregated with the clinical phenotypes in this family. RT-PCR analysis revealed that cdhr1 is ubiquitously expressed in eye, particularly very high expression in retina; high expression in lens, sclera, and cornea; and high expression in brain. In conclusion, our study is the first to indicate that the novel homozygous variant c.T1641A (p.Y547*) in the CHDR1 gene might be the disease-causing mutation for retinal dystrophy in our patient, extending its mutation spectrums. These findings further the understanding of the molecular pathogenesis of this disease and provide new insights for diagnosis as well as new implications for genetic counselling.
inheritance, presenting early loss of cone photoreceptors and a parallel or subsequent loss of rod photoreceptors. The loss of cone photoreceptor cells leads to visual loss, visual field loss, abnormalities of colour vision and variable degrees of photophobia and nystagmus, whereas the loss of rod function leads to night blindness. 5 In many cases, successive generations (50%~60%) are inherited as autosomal recessive, resulting from homozygous mutations in the RP-related genes. Mutations in the CDHR1 gene (OMIM 609502) lead to autosomal recessive retinal dystrophy or autosomal recessive CRD (OMIM 613660). [5] [6] [7] The CDHR1 (Cadherin-Related Family Member 1), also called and immunoprecipitation studies showed that CDHR1 are also found in complexes with PROM1 and actin filaments, playing a critical role in photoreceptor disk morphogenesis. 10 Here, we applied targeted next-generation sequencing (TGS) technology, the most available and promising method available, [11] [12] [13] [14] [15] [16] to identify a novel, homologous mutation of CDHR1 gene in a Chinese family with autosomal recessive retinal dystrophy, extending the gene's mutation spectrum.
| MATERIALS AND METHODS

| Ethical statement, proband and clinical assessment
The research was approved by the Ethical Committees of the Southwest Medical University; written informed consent conforming to the tenets of the Declaration of Helsinki (1983 Revision) was obtained from all participants. 17 The study consisted of a proband ( were used in previously studies.
17-19
| Blood sampling and DNA extraction
Two millilitres of fresh peripheral bloods were taken, and human genomic DNAs (gDNAs) were extracted using the previously described standard phenol/chloroform method from blood leucocytes of the proband and pedigree members who were accessible. 20, 21 Blood samples were also taken from 100 RP-unrelated, ethnically matched and healthy control volunteers no any disease history.
| Capture panel designing, exome sequencing
To access the disease-causing genes and mutations, the panels for TES analyses on the DNA sample from the proband M341 were designed, according to the Illumina paired-end libraries (Illumina, Inc., San Diego, CA, USA). 11, 12, 14 The capture Agilent probes were used in previously published studies. 11, 12, 14, 18, 22 
| Primer design, PCR amplification and Sanger sequencing
For mutation verification and co-segregation analysis, polymerase chain reaction (PCR) amplification and direct Sanger sequencing of variant was applied to gDNA of all the available individuals. 18 Locus-specific primer pair (CDHR1-1641) was designed from the online Primer3 program (http://primer3.ut.ee/) by genomic DNA sequences containing identified mutation c.T1641A in CDHR1 (Table 1) . A product with 208 bps was amplified using gDNA as the template. Then, the PCR products were sequenced by Sanger method on an ABI-3500DX sequencer (Applied Biosystems Inc.,
Foster City, CA, USA) through the specific primer CDHR1-1641L in Table 1 . All unrelated ethnical-matched controls were sequenced using aforementioned primers.
| Protein structure and bioinformatic analysis
The functional classification of proteins via subfamily domain architectures for CDHR1 was performed through an online NCBI system (https://www.ncbi.nlm.nih.gov/Structure/cdd/wrpsb.cgi). 19, 29, 30 Comparison of CDHR1 in different species was also performed by previously online NCBI system.
| RNA extraction and revere transcriptionalpolymerase chain reaction (RT-PCR)
RNAs from mice with indicated ages and indicated tissues were extracted using RNAsimple Total RNA kit according to our previously reported standard protocols, 31 Then, the total amount of RNA in each reaction system is equal to 500 ng for cDNA synthesis (reverse transcriptase/RT) using random oligomer primers method and RT kit. The primer sequences, product size and PCR conditions (anneal temperature) are listed in Table 1 . Semi-quantitative RT-PCR with a 383 bps product was performed by primer pair RT-cdhr1 for mouse cdhr1 gene; ß-actin gene of mouse was served as an internal control by primer pair RTb-actin-m (Table 1) . Each assay was performed in three independent tests.
| RESULTS
| Pedigree and clinical characteristics
The 
| Mutation verification and segregation analysis
Albeit deficient, the Sanger sequencing was used for confirmation and segregation analysis (Figure 4) . (p.Y547*) is a novel mutation, extending its mutation spectrums.
Thus, this finding shows that the recessive CDHR1 mutations, c.T1641A (p. Y547*), likely cause disease of retinal dystrophy in our studied Chinese pedigree.
The pathogenic CDHR1 mutation was first identified in 2010, 5, 7 and only a few mutations have been reported since then. CDHR1 is highly expressed in the retina, more specifically in the junction between the inner and outer segments (OS) of rod and cone photoreceptors. 9 Our study using the mouse model shown that cdhr1 mRNA levels are very highly expressed in retina; highly expressed in lens, sclera, cornea and brain; and weakly expressed in skeletal muscle in 15 different tissues. High expression in the 6 different development stages/times of retina was also shown. Higher | 5667 expression in brain is consistent with the report made by Nakajima et al, 8 but not the report made by Rattner et al. 9 But no matter what, higher expression in retina and ubiquitous expressions in different tissues of eye indicated that CDHR1 plays an important role in retina/eye functions.
In conclusion, our study was the first to identify that the homozygous variant c.T1641A (p.Y547*) of the CHDR1 gene is most likely the disease-causing mutation for retinal dystrophy in our Chinese patient, extending its mutation spectrums. Targeted next-generation sequencing (TGS) technology provides us an accurate, rapid and cost-effective molecular method for gene diagnosis. These findings facilitate better understanding of the molecular pathogenesis of the disease, provide new insights for diagnosis and have implications for genetic counselling.
